
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation EBITDA per Share 2011-2026 | NVTA
EBITDA per Share Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | -0.64 | -4.56 | -2.51 | -1.63 | -2.41 | -2.82 | -2.98 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.2 | -4.56 | -2.17 |
EBITDA per Share Vierteljährlich Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.54 | -0.84 | -0.56 | - | -1.18 | -10.8 | -0.81 | -0.94 | -0.62 | 0.8 | -0.49 | -1.78 | -0.44 | -0.99 | -0.92 | -0.8 | -0.69 | -0.5 | -0.41 | -0.34 | -0.28 | -0.34 | -0.61 | -0.65 | -0.52 | -0.57 | -0.61 | -0.61 | -0.62 | -0.67 | -0.75 | -0.76 | -0.59 | -0.69 | -1.03 | -16.2 | -12.4 | -11.6 | -11.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.8 | -16.2 | -2.28 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
5.49 | $ 115.39 | -1.31 % | $ 35.1 B | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-4.37 | $ 1.16 | -1.69 % | $ 6.32 M | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 16.69 | -6.86 % | $ 889 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.25 | 0.06 % | $ 175 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 23.43 | -6.99 % | $ 651 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 175.55 | 0.27 % | $ 8.7 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
7.63 | $ 192.99 | -1.63 % | $ 138 B | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 2.3 | 16.02 % | $ 10.2 M | ||
|
Illumina
ILMN
|
-3.01 | $ 123.67 | -3.38 % | $ 19.7 B | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 15.02 | -5.12 % | $ 454 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.61 | $ 28.13 | 0.29 % | $ 20 B | ||
|
Guardant Health
GH
|
-3.17 | $ 87.17 | -6.11 % | $ 10.9 B | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-361 | $ 2.74 | 0.37 % | $ 88.9 K | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.2 | 2.33 % | $ 5.05 M | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 106.7 | 0.15 % | $ 8.8 B | ||
|
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 273.26 | -0.53 % | $ 22.7 B | ||
|
Celcuity
CELC
|
-3.68 | $ 124.64 | 6.58 % | $ 5.83 B | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 501.5 | -3.68 % | $ 14.5 B | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 81.43 | 1.75 % | $ 5.5 B | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 4.44 | -6.92 % | $ 411 M | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 197.82 | -0.5 % | $ 22 B | ||
|
NeoGenomics
NEO
|
-0.62 | $ 7.94 | -3.38 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 10.04 | -2.95 % | $ 2.18 B | ||
|
ENDRA Life Sciences
NDRA
|
-7.27 | $ 5.31 | 2.71 % | $ 4.18 M | ||
|
National Research Corporation
NRC
|
1.35 | $ 17.05 | -1.22 % | $ 382 M | ||
|
Natera
NTRA
|
-5.33 | $ 203.0 | -3.71 % | $ 20 B | ||
|
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
0.11 | - | -16.95 % | $ 1.54 M |